University of Guam associate director Else Demeulenaere, Ph.D., has contributed to research that reclassified Caesalpinioidea ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

Brazil has reported its first clade 1b mpox case, per a notice from the national Health Ministry.

Prior exposures to specific types of seasonal influenza viruses promote cross-reactive immunity against the H5N1 avian ...

Bethesda, Maryland Saturday, March 15, 2025, 10:00 Hrs [IST] ...

ATLANTA, GA - February 19, 2025 (NEWMEDIAWIRE) - The confirmation of a fourth case of Clade 1 Mpox in New York underscores the urgent need for a stronger and more diversified vaccine supply chain.

The mpox virus has mutated, and the new variant, clade 1b, has become more infectious. International researchers, including from DTU National Food Institute, warn that the ongoing mpox outbreak in ...

Photo: Courtesy of Institute of Vertebrate Paleontology and Paleoanthropology (IVPP) of the Chinese Academy of Sciences A new ...

A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...